Biocept Cash Conversion Cycle 2011-2026 | BIOC

Annual Cash Conversion Cycle Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.1	29.9	51.8	124	421	151	-43.7	-67.8	-516	-24.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
421	-516	20.3

Quarterly Cash Conversion Cycle Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
117	197	-	241	222	27.2	-	46.5	71.5	27.4	-	95.8	1.17 K	438	141	170	228	180	113	135	126	115	79.6	69.7	55.4	10.5	-10.7	-8.77	-4.74	12.1	-5.97	-3.36	15.1	-15.6	-54.4	17.4	-64.7	-99.8	44.6	-187	-205	-109	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.17 K	-205	87.2

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 201.42	-0.84 %	$ 22.4 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-2.46 K	$ 4.0	-6.76 %	$ 5.32 M	USA
Castle Biosciences CSTL	31.6	$ 20.83	0.63 %	$ 604 M	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	2.11	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	51.8	$ 18.67	-0.05 %	$ 575 M	USA
Guardant Health GH	79.6	$ 131.64	0.02 %	$ 16.5 B	USA
CareDx, Inc CDNA	51.5	$ 23.44	2.02 %	$ 1.25 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	52.5	$ 146.34	0.11 %	$ 11.5 B	Irlanda
Interpace Biosciences IDXG	62.9	$ 1.64	2.19 %	$ 7.26 M	USA
Illumina ILMN	147	$ 165.6	2.88 %	$ 25.7 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Lantheus Holdings LNTH	97.3	$ 104.33	-0.18 %	$ 7.04 B	USA
Charles River Laboratories International CRL	65	$ 190.08	1.37 %	$ 9.42 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	50.4	$ 468.18	0.18 %	$ 13.5 B	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	66.4	$ 1 152.81	2.1 %	$ 23.8 B	Schweiz
Myriad Genetics MYGN	49.3	$ 4.31	-0.58 %	$ 399 M	USA
NeoGenomics NEO	82.4	$ 11.08	-0.63 %	$ 1.42 B	USA
National Research Corporation NRC	29.4	$ 18.37	-2.24 %	$ 411 M	USA
Natera NTRA	48.3	$ 215.44	1.59 %	$ 29.5 B	USA
Pacific Biosciences of California PACB	185	$ 1.39	5.73 %	$ 417 M	USA
Personalis PSNL	-1.89	$ 9.99	4.17 %	$ 892 M	USA
Koninklijke Philips N.V. PHG	89	$ 26.73	1.0 %	$ 25.3 B	Niderland
Senseonics Holdings SENS	36.1	$ 7.27	1.18 %	$ 303 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	-398	-	-	$ 2.69 B	USA
Biomerica BMRA	172	$ 2.01	-1.95 %	$ 4.62 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 263.91	-0.74 %	$ 22 B	USA
Twist Bioscience Corporation TWST	83.6	$ 80.85	6.14 %	$ 4.84 B	USA
Thermo Fisher Scientific TMO	70	$ 472.33	0.74 %	$ 178 B	USA
Trinity Biotech plc TRIB	136	$ 0.66	1.0 %	$ 237 M	Irlanda
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	150	$ 9.1	-0.05 %	$ 1.97 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA